Doctors Increasingly Becoming 'Nursing Home Specialists'

Share this content:
Doctors Increasingly Becoming 'Nursing Home Specialists'
Doctors Increasingly Becoming 'Nursing Home Specialists'

WEDNESDAY, Nov. 29, 2017 (HealthDay News) -- From 2012 to 2015 there was a relative increase in the number of nursing home specialists, including an increasing number of generalist physicians billing for nursing home care, according to a research letter published in the Nov. 28 issue of the Journal of the American Medical Association.

Kira L. Ryskina, M.D., from the University of Pennsylvania Perelman School of Medicine, and colleagues used the Provider Utilization Files to identify generalist physicians and advanced practitioners who provided nursing home-based care from 2012 to 2015. Episodes of care were aggregated by clinician to measure the proportion of episodes that were nursing home-based. Clinicians who billed at least 90 percent of episodes from the nursing home were defined as nursing home specialists.

The researchers found that 15.7 percent of the 319,264 unique generalist clinicians billed for nursing home care from 2012 through 2015. The number of clinicians billing for nursing home care remained relatively stable (−0.4 percent), while there was an increase of 15.6 percent in the total number of generalists. There was a relative increase of 33.7 percent in the number of nursing home specialists (5,127 to 6,857; P for trend < 0.001). From 2012 to 2015 there was an increase in the number of nursing home specialists per 1,000 beds, from 3.35 to 4.58 (P for trend < 0.001).

"Whether these changes improve outcomes (e.g., through increased access to expert clinicians) or result in adverse consequences (e.g., due to worsened care fragmentation) requires ongoing study," the authors write.

One author disclosed financial ties to Pfizer.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A&#43;AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »